LPTX

Leap Therapeutics, Inc. LPTX

LPTX
Leap Therapeutics, Inc. CTXR
Citius Pharmaceuticals, Inc. ATHA
Athira Pharma, Inc. CRIS
Curis, Inc. PCSA
Processa Pharmaceuticals, Inc. APLM
Apollomics, Inc. ICU
SeaStar Medical Holding Corporation BCTX
BriaCell Therapeutics Corp. ASBP
Aspire Biopharma Holdings, Inc. ENTO
Entero Therapeutics, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode LPTX CTXR ATHA CRIS PCSA APLM ICU BCTX ASBP ENTO
6M 314.45 % -33.28 % 131.09 % -51.61 % -46.58 % 196.38 % -42.79 % -72.39 % -59.52 % 89.21 %
YTD -63.66 % -79.37 % 31.09 % -75.24 % -84.41 % 66.57 % -87.59 % -90.70 % -99.16 % 35.57 %
1Y -60.74 % -75.81 % 33.77 % -66.56 % -85.33 % 71.50 % -88.42 % -89.93 % -99.16 % 39.15 %
3Y -72.98 % -96.02 % -75.81 % -88.83 % -99.40 % -98.26 % -99.77 % -98.74 % -99.16 % -98.74 %
5Y -94.71 % -97.01 % -97.74 % -99.33 % -99.90 % -98.18 % -99.91 % -98.68 % -99.16 % -100.00 %
10Y -98.51 % -99.88 % -95.79 % -99.63 % -99.56 % -98.18 % -99.91 % 5 226.92 % -99.16 % -100.00 %
Depuis le début -98.51 % -99.79 % -95.79 % -99.96 % -99.96 % -98.18 % -99.91 % 1 644.55 % -99.16 % -100.00 %

Dividende